Glioblastoma (GBM)
Oncology·MeSH: Glioblastoma
Prevalence
3.2 / 100K
Incidence
3.2 / 100K/yr
13 drugs in development·7 companies·4 clinical trials
Drug Pipeline by Phase
Phase 3(1)
Phase 2(7)
Compare drugs
Frequently asked questions
How many drugs are in development for Glioblastoma (GBM)?
BioSniper tracks 13 drugs in development for Glioblastoma (GBM) across 7 companies.
How many clinical trials target Glioblastoma (GBM)?
There are 4 clinical trials targeting Glioblastoma (GBM) tracked by BioSniper.
What is the prevalence of Glioblastoma (GBM)?
The estimated prevalence of Glioblastoma (GBM) is approximately 3.2 per 100,000 population.
Deep-dive into Glioblastoma (GBM)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis